The Epidemiology of Sepsis in Childhood

Daniela Carla de Souza1, Eliane Roseli Barreira, Lucília Santana Faria

  • 1*Pediatric Intensive Care Unit, Hospital Sirio Libanes, São Paulo, Brazil †Pediatric Intensive Care Unit, University Hospital, University of São Paulo, São Paulo, Brazil.

Shock (Augusta, Ga.)
|July 26, 2016
PubMed

Insights

Pediatric sepsis, a serious infection, is rising globally, especially in low-income countries. Early recognition and treatment are crucial for improving survival rates in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Sepsis (systemic inflammatory response to infection) is a significant cause of childhood mortality worldwide.
  • A comprehensive global understanding of pediatric sepsis epidemiology and mortality is lacking.

Purpose of the Study:

  • To review the existing literature on pediatric sepsis epidemiology and mortality.
  • To highlight trends and challenges in managing pediatric sepsis globally.

Main Methods:

  • A non-systematic review of medical articles.
  • Literature search conducted on Medline database.
  • Articles published between 2005 and 2015 were analyzed.

Main Results:

  • Pediatric sepsis cases have increased over the past two decades, potentially due to improved survival of high-risk infants.
  • Children in low-income countries are particularly vulnerable.
  • High mortality rates (5-40%) persist, primarily due to delayed diagnosis and treatment, not resource limitations.

Conclusions:

  • Educational initiatives for the public and healthcare providers can improve sepsis survival.
  • Standardized definitions and adaptable diagnostic criteria are essential for global pediatric sepsis management.
  • Addressing delays in recognition and treatment is key to reducing mortality.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K